Weekly Research Analysts’ Ratings Changes for USANA Health Sciences (USNA)

A number of firms have modified their ratings and price targets on shares of USANA Health Sciences (NYSE: USNA) recently:

• 1/2/2025 – USANA Health Sciences had its price target raised by analysts at DA Davidson from $35.00 to $38.00. They now have a “neutral” rating on the stock.
• 12/28/2024 – USANA Health Sciences was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating.
• 12/20/2024 – USANA Health Sciences was upgraded by analysts at DA Davidson to a “hold” rating.
• 12/19/2024 – USANA Health Sciences was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating.

USANA Health Sciences Price Performance

Shares of NYSE:USNA opened at $35.32 on Wednesday. The business has a fifty day moving average price of $37.77 and a 200-day moving average price of $39.36. The company has a market capitalization of $673.20 million, a PE ratio of 12.48, a PEG ratio of 1.25 and a beta of 0.89. USANA Health Sciences, Inc. has a 1-year low of $31.44 and a 1-year high of $52.75.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. During the same quarter last year, the firm earned $0.59 earnings per share. On average, sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.33% of the stock is owned by company insiders.

Institutional Investors Weigh In On USANA Health Sciences

A number of institutional investors and hedge funds have recently bought and sold shares of USNA. Exchange Traded Concepts LLC grew its holdings in USANA Health Sciences by 4.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after buying an additional 322 shares in the last quarter. Martingale Asset Management L P boosted its position in shares of USANA Health Sciences by 2.1% during the third quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after acquiring an additional 340 shares during the last quarter. KBC Group NV grew its stake in USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after acquiring an additional 519 shares in the last quarter. Safe Harbor Fiduciary LLC bought a new stake in USANA Health Sciences in the 3rd quarter valued at $30,000. Finally, Public Sector Pension Investment Board lifted its stake in USANA Health Sciences by 5.4% in the 2nd quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company’s stock worth $1,098,000 after purchasing an additional 1,242 shares in the last quarter. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.